$100 BILLION

The cost of treating autoimmune diseases is estimated at more than $100 billion annually in the U.S.⁴ Gastrointestinal diseases have many causes, including autoimmune issues. One example is Crohn’s Disease, a costly, chronic illness with drug costs overtaking inpatient hospital expenses as the top cost driver.

26% LESS

One way to push back against these costs is to have integrated medical and pharmacy benefits. Improved management of GI diseases like Crohn's Disease has resulted in a 26% reduction in costs, a savings of $121 PMPM/$1,452 PMPY.⁵

$3 BILLION

More than 29% of U.S. adults have reported a depression diagnosis in their lifetime.⁶ Direct and indirect costs tied to depressive disorders represent a $3 billion cost to U.S. businesses.⁷

13% LESS

Members diagnosed with a depression disorder cost 13% less, or saved $73 PMPM/$876 PMPY when medical and pharmacy benefits were connected.⁸

17.9 Million

Cardiovascular disease is the leading cause of death globally, leading to an estimated 17.9 million lives lost each year.⁹ With so many factors connected to CVD, it demands a more holistic approach. Studies have shown, for example, that pharmacist-led interventions in cardiac rehabilitation significantly improved patient outcomes.¹⁰

15% SAVINGS

The HealthScape studies found that members with conditions related to cardiovascular disease, including high cholesterol, showed 15% savings ($55 PMPM/$660 PMPY).¹¹

1 in 7 ADULTS

Chronic Kidney Disease affects more than 1 in 7 U.S. adults — an estimated 35.5 million Americans.¹² And, as many as 9 in 10 adults who have CKD are not aware they have the disease. Early-stage kidney disease usually has no symptoms, and many people don’t know they have CKD until it is very advanced.¹³

23% SAVINGS

This is why it’s so critical to connect benefits and engage with employees as often as possible. Members diagnosed with CKD experienced 23% ($92 PMPM/$1,104 PMPY) savings when using carved in pharmacy benefits.¹⁴

$412.9 BILLION

Cases of diabetes globally are projected to surpass one billion by 2050.¹⁵ Diabetes-related complications can escalate quickly to high-risk situations or life-threatening emergencies which can also result in higher medical costs. According to a report by the American Diabetes Association, the annual cost of diabetes is $412.9 billion.¹⁶

19% LESS

In aggregate, members with diabetes diagnoses who had connected pharmacy benefits cost their employers 19% less, or an average of $70 PMPM/$840 PMPY savings.¹⁷

34 MILLION

About 34 million U.S. adults who should be medicated according to high blood pressure guidelines may need a prescription or to fill their prescription and start taking it.¹⁸ One key to better care and medication adherence is being able to more holistically and individually understand patients’ concerns and barriers.

17% SAVINGS

Connected medical and pharmacy benefits helped improve outcomes for members with cardiovascular disease, and lowered the costs of cardiac-related care.

Treatment of high blood pressure showed a savings of 17% or $68 PMPM/$816 PMPY.¹⁹